benzydamine has been researched along with Cancer of Esophagus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dong, Z; Guo, Y; He, X; Jiang, Y; Li, J; Liu, K; Liu, Z; Wang, Z; Wu, W; Yu, Y; Zhang, C; Zhao, J; Zhou, Y | 1 |
1 other study(ies) available for benzydamine and Cancer of Esophagus
| Article | Year |
|---|---|
Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma.
Topics: Apoptosis; Benzydamine; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Molecular Docking Simulation; Phosphorylation | 2023 |